What does positron emission tomography offer oncology?

被引：19

作者：

Anderson, H ^{[1
]}

Price, P ^{[1
]}

机构：

[1] Hammersmith Hosp, Imperial Coll, Sch Med, MRC Cyclotron Unit,CRC PET Oncol Grp, London W12 0NN, England

来源：

EUROPEAN JOURNAL OF CANCER | 2000年 / 36卷 / 16期

关键词：

positron emission tomography; radionuclides; F-18]-FDG;

D O I：

10.1016/S0959-8049(00)00292-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The origins of positron emission tomography (PET) dare back 70 years. Since the 1970s, however, its use has increased exponentially in the fields of neurology, cardiology and oncology. [F-18]-Fluorodeoxyglucose (FDG) whole-body scanning is by far the most widely utilised and recognised application of PET in oncology. However, PET is a very versatile and powerful imaging modality capable of helping bridge the gap between the laboratory and the clinic. This article reviews the history and current applications of PET in oncology and then explores some of the newer applications and potential future uses of this versatile technology particularly in the area of cancer research. (C) 2000 Elsevier Science Ltd. All rights reserved.

引用

收藏

页码：2028 / 2035

页数：8

相关论文

共 92 条

[1] Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings [J].

Abdel-Nabi, H ;

Doerr, RJ ;

Lamonica, DM ;

Cronin, VR ;

Galantowicz, P ;

Carbone, GM ;

Spaulding, MB .

RADIOLOGY, 1998, 206 (03) :755-760

[2] ASSESSMENT OF RADIOTHERAPEUTIC EFFECTS ON EXPERIMENTAL-TUMORS USING F-18 2-FLUORO-2-DEOXY-D-GLUCOSE [J].

ABE, Y ;

MATSUZAWA, T ;

FUJIWARA, T ;

FUKUDA, H ;

ITOH, M ;

YAMADA, K ;

YAMAGUCHI, K ;

SATO, T ;

IDO, T .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1986, 12 (07) :325-328

[3]

Aboagye EO, 1997, CANCER RES, V57, P3314

[4] The value of positron emission tomography scanning in the detection of subclinical metastatic melanoma [J].

Acland, KM ;

O'Doherty, MJ ;

Russell-Jones, R .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (04) :606-611

[5] Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors [J].

Alauddin, MM ;

Shahinian, A ;

Kundu, RK ;

Gordon, EM ;

Conti, PS .

NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (04) :371-376

[6] Energies of cosmic-ray particles [J].

Anderson, CD .

PHYSICAL REVIEW, 1932, 41 (04) :405-421

[7] The role of PET-FDG when there is diagnostic doubt concerning relapse of radionecrosis of cerebral tumours [J].

Asensio, C ;

Perez-Castejon, MJ ;

Maldonado, A ;

Montz, R ;

Ruiz, JA ;

Santos, M ;

Garcia-Berrocal, I ;

Albert, J ;

Carreras, JL .

REVISTA DE NEUROLOGIA, 1998, 27 (157) :447-452

[8]

Bader JB, 1998, RADIOLOGE, V38, P924, DOI 10.1007/s001170050443

[9] Results of positron emission tomography with fluorine-18-labelled fluorodeoxyglucose in staging and differential diagnosis of pancreatic cancer [J].

Bares, R ;

Dohmen, BM ;

Cremerius, U ;

Fass, J ;

Teusch, M ;

Bull, U .

RADIOLOGE, 1996, 36 (05) :435-440

[10]

Bergström M, 1998, J NUCL MED, V39, P1273

← 1 2 3 4 5 6 7 8 9 10 →